Stockreport

Bicara Therapeutics Announces Upcoming Presentations at AACR Annual Meeting 2025

Bicara Therapeutics Inc.  (BCAX) 
PDF BOSTON, March 25, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bif [Read more]